Abstract
In patients with drug refractory atrial tachyarrhythmias and previous failed attempts of ablation of the arrhythmia substrate, radiofrequency (RF) modulation or ablation of the atrioventricular (AV) junction is an alternative procedure.
Aim of this study was to assess the efficacy and long term results of RF AV junction ablation in conjunction with permanent pacemaker implantation, in the management of patients with drug resistant atrial tachyarrhythmias.
Methods: Between 4/92 and 1/97, 46 patients (30 male, 16 female, 67±12 years) underwent RF AV junction ablation because of paroxysmal atrial fibrillation (24 patients), chronic atrial fibrillation (13 patients), atrial flutter (5 patients) and atrial tachycardia (4 patients). The underlying heart disease was dilated cardiomyopathy (16), ischemic heart disease (9), hypertensive heart disease (6), hypertrophic cardiomyopathy (3), atrial septal defect (2) and non structural heart disease (10). The duration of symptoms was 6.4±3.5 years at a maximal heart rate 169±24 bpm. The hospital admissions in the last 12 months were 8.2±3 per patient. The failed antiarrhythmic drugs were 3.5±2.1. The functional NYHA class was 2.7±0.6. Patients with atrial flutter and atrial tachycardia had previous failed attempts of RF ablation of the arrhythmia substrate. Thirty patients had a compromised left ventricular systolic function with LVEF below 50% (mean 34±9%). AV junction ablation was achieved in all patients after 4±2.5 RF applications. Post ablation, the selected pacing mode was DDD-R for the 33 patients with paroxysmal atrial tachyarrhythmias and VVI-R for the 13 pts with chronic atrial fibrillation. The dual chamber pacemakers implanted had the option of automatic mode switch.
Results: During the follow-up period of 28±13 months (6–47), AV conduction recovered in 1 patient. Antiarrhythmic treatment was necessary in only 7 patients. Post ablation the new functional NYHA class was 1.4±0.8 (p < 0.001). Post ablation hospital admissions, including ordinary pacemaker follow-up visits, were 4±1 per patient per year (p < 0.001). Six months after the procedure the LVEF of the study population was increased from 42±16% to 50±14% (p = NS). In the 30 patients with heart failure the LVEF was significantly increased to 46±8% (p < 0.05). Symptomatic relief or significant improvement was observed in all patients as showed by the answers given in a customized questionnaire before and after the procedure.
Conclusions: In patients with drug refractory atrial tachyarrhythmias, RF AV junction ablation and permanent pacemaker implantation is an alternative therapy with excellent long term results in terms of arrhythmia control, ventricular performance and quality of life.
Article PDF
Similar content being viewed by others
References
Grogan M, Smith HC, Gersh B. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69: 1570–1573.
Daoud E, Weiss R, Bahu M, et al. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996; 78:1433–1436.
Lemery R, Brugada P, Cheriex E. Reversibility of tachycardia induced left ventricular dysfunction after closed-chest ablation of the atrioventricular junction for atrial fibrillation. J Am Coll Cardiol 1987;60:1406–1408.
Rosenqvist M, Lee MA, Moulinier L, et al. Long term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction. J Am Coll Cardiol 1990;16: 1467–1474.
Heinz G, Siostrzonek P, Kreiner G, et al. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol 1992;69: 489–492.
Rodriguez LM, Smeets JLRM, Xie B, et al. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol 1993;72:1137–1141.
Sutton R. Mode switching in DDDR pacing. In: Aubert A, Ector H, Stroobandt R, eds. Cardiac Pacing and Electrophysiology. A Bridge to the 21st Century. The Netherlands: Kluwer Acad. Publ. 1994;363–370.
Flaker GC, Blackshear JL, McBride R, et al. Antiarrhytmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992;20:527–532.
Packer MP, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with heart failure. N Engl J Med 1996;334:1349–1355.
Twidale N, Sutton K, Bartlet L, et al. Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug refractory atrial arrhythmias. PACE 1993;16:1275–1284.
Brignole M, Gianfranchi L, Menozzi C, et al. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 1994;74:242–246.
Natale A, Zimerman L, Tomassani G, et al. Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response. Am J Cardiol 1996; 78:1431–1433.
Hardman SMC, Noble MIM, Seed WA. Postextrasystolic potentiation and its contribution to the beat to beat variation of the pulse during atrial fibrillation. Circulation 1992;86: 1223–1232.
Noble MIM. The Frank-Starling curve. Clin Sci Mol Med. 1978;54:1–7.
Gosselink ATM, Blanksma PK, Crijns HJG, et al. Left ventricular beat to beat performance in atrial fibrillation: contribution of Frank-Starling mechanism after short rather than long RR intervals. J Am Coll Cardiol 1995;26:1516–1521.
Katz AM. Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N Engl J Med 1990; 322:100–110.
Fitzpatrick AP, Kourouyan HD, Siu A, et al. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J 1996;131:499–507.
Dulk K, Dijkman B, Pieterse M, Wellens H. Initial experience with mode switching in a dual sensor, dual chamber pacemaker in patients with paroxysmal atrial tachyarrhythmias. PACE 1994;17(pt II):1900–1907.
Ousyshcher I, Katz A, Bondy C. Initial experience with a new algorithm for automatic mode switching from DDD-R to DDI-R mode. PACE 1994;17(pt II):1908–1912.
Ricci R, Puglisi A, Azzolini P, et al. Reliability of a new algorithm for automatic mode switching from DDD-R to DDI-R pacing mode in sinus node disease patients with chronotropic incompetence and recurrent paroxysmal atrial fibrillation. PACE 1996;1719–1723.
Jordaens L, Rubben L, Vertongen P. Sudden death and long term survival after ablation of the atrioventricular junction. Eur J CPE 1993;3:232–237.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Manolis, A.G., Katsivas, A.G., Lazaris, E.E. et al. Ventricular Performance and Quality of Life in Patients Who Underwent Radiofrequency AV Junction Ablation and Permanent Pacemaker Implantation Due to Medically Refractory Atrial Tachyarrhythmias. J Interv Card Electrophysiol 2, 71–76 (1997). https://doi.org/10.1023/A:1009721008761
Issue Date:
DOI: https://doi.org/10.1023/A:1009721008761